Bioxytran (BIXT) Enterprise Value (2011 - 2026)
Bioxytran (BIXT) posted Enterprise Value of $3.26 million for Q2 2026, down 63.3% from $8.9 million a year earlier and down 19.8% from the prior quarter.
Bioxytran (BIXT) Enterprise Value (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Enterprise Value at Bioxytran was $2.28 million, down 74.3% year-over-year; for FY2025, it was $8.14 million, down 34.7% from FY2024.
- Annual Enterprise Value has declined for three consecutive years, with a five-year compound annual growth rate of -19.6% (FY2020 to FY2025).
- In prior years, Bioxytran's Enterprise Value was $12.47 million in FY2024 (-41.0%), $21.14 million in FY2023 (-63.7%), $58.28 million in FY2022 (+32.8%) and $43.87 million in FY2021 (+81.0%).
- The Q2 2026 figure stands as the lowest quarterly Enterprise Value in data going back to Q1 2011.
- On a year-over-year basis, Enterprise Value has declined in each of the last 13 quarters, with an average decline of 47.9% over the last eight quarters.
- The strongest year-over-year quarter for Enterprise Value in the past five years was Q1 2023, with growth of 203.4%; the weakest was Q3 2023, with a decline of 71.7%.
- According to Business Quant data, Enterprise Value for the three prior quarters was $4.07 million (Q1 2026), $8.14 million (Q4 2025) and $6.21 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.26 Mn |
| Mar 31, 2026 | 4.07 Mn |
| Dec 31, 2025 | 8.14 Mn |
| Sep 30, 2025 | 6.21 Mn |
| Jun 30, 2025 | 8.90 Mn |
| Mar 31, 2025 | 12.44 Mn |
| Dec 31, 2024 | 12.47 Mn |
| Sep 30, 2024 | 13.87 Mn |
| Jun 30, 2024 | 17.03 Mn |
| Mar 31, 2024 | 18.33 Mn |
| Dec 31, 2023 | 21.14 Mn |
| Sep 30, 2023 | 23.80 Mn |
| Jun 30, 2023 | 24.42 Mn |
| Mar 31, 2023 | 53.56 Mn |
| Dec 31, 2022 | 58.28 Mn |
| Sep 30, 2022 | 83.97 Mn |
| Jun 30, 2022 | 34.97 Mn |
| Mar 31, 2022 | 17.66 Mn |
| Dec 31, 2021 | 43.87 Mn |
| Mar 31, 2021 | 18.20 Mn |
Bioxytran Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=BIXT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();